Der Onkologe

, Volume 13, Issue 9, pp 813–822

Kolorektales Karzinom

Andere Therapiemodalitäten bei älteren Patienten?
Leitthema

Zusammenfassung

Die Rate an betagten Patienten über 75 Jahre – und damit auch die Inzidenz des kolorektalen Karzinoms – nimmt in Europa weiter zu. Ebenfalls steigend ist die durchschnittliche Lebenserwartung. Für Patienten bis 75 Jahre wurden Therapiestandards etabliert. Gilt dies auch für betagte Patienten? In diesem Artikel wird die Problematik der Entscheidungskaskade bei älteren Patienten mit einem kolorektalen Karzinom dargestellt. Es soll gezeigt werden, dass bei risikoadaptierter Operations- und Behandlungsindikation ältere Patienten mit einem kolorektalen Karzinom eine vertretbare Morbidität gegenüber jüngeren Patienten und eine vergleichbare onkologische Prognose haben.

Schlüsselwörter

Alter Risikoadaption Interdisziplinarität Multimodalität Prognose 

Colorectal cancer

Other therapy modalities for older patients?

Abstract

The rate of patients aged over 75 years in Europe is still increasing and consequently the incidence of colorectal cancer is also increasing. The average life-expectation is also on the increase. For patients aged below 75 years old standards of therapy have been established, but does this also apply to elderly patients? In this article the decision cascade in elderly patients with colorectal cancer is examined. It should be shown that in cases of risk-adapted therapy and operation indications, elderly patients with colorectal cancer have a justifiable morbidity and a comparable oncological prognosis compared with younger patients.

Keywords

Age Riskadaption Multidisciplinarity Multimodality Prognosis 

Literatur

  1. 1.
    Andre T et al. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351PubMedCrossRefGoogle Scholar
  2. 2.
    Becker N, Warendorf J (1998) Krebsatlas der Bundesrebublik Deutschland. Springer, Berlin Heidelberg New York, S 161–188Google Scholar
  3. 3.
    Beets-Tan RGH et al. (2001) Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 357:497–504PubMedCrossRefGoogle Scholar
  4. 4.
    Beller S, Schlag PM (2006) Hat die palliative Resektion bei gastrointestinalen Tumoren noch einen Stellenwert? Chirurg 10.1007/s00104-006-1164-9Google Scholar
  5. 5.
    Bujko K, Nowacki MD, Nasierowska-Guttmejer A et al. (2006) Long term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. British J Surg 93:1215–1223CrossRefGoogle Scholar
  6. 6.
    Cedermark B, Johannsen H, Rutqvist LE et al. (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial-Stockholm Colorectal Cancer Study Group. Cancer 75:2269–2275PubMedCrossRefGoogle Scholar
  7. 7.
    Colorectal Cancer Collaborative Group (2000) Surgery for colorectal cancer in elderly patients:a systematic review. Lancet 356:968–974CrossRefGoogle Scholar
  8. 8.
    Deutsche Krebsgesellschaft (1994) Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon- und Rektumkarzinomen vom 11.03.1994. Onkologie 17:291–293CrossRefGoogle Scholar
  9. 9.
    Dohmoto M, Huenerbein M, Schlag PM (1997) Application of rectal stents for palliation of obstructing rectosigmoid cancer. Surg Endos 11:758–761CrossRefGoogle Scholar
  10. 10.
    Frykholm GJ, Pahlmann L, Glimelius B (1995) Treatment of local recurrence of rectal carcinoma. Radiother Oncol 34:185–194PubMedCrossRefGoogle Scholar
  11. 11.
    Gastrointestinal Tumor Study Group (1984) Adjuvant therapy of colon cancer. Results of a prospectively randomized trial. N Engl J Med 310:737–743CrossRefGoogle Scholar
  12. 12.
    Glimelius B (2002) Radiotherapy in rectal cancer. Br Med Bull 64:141–157PubMedCrossRefGoogle Scholar
  13. 13.
    Golfinopoulos V, Pentheroudakis G, Pavlidis N (2006) Treatment of colorectal cancer in the elderly:A review of the literature. Cancer Treat Rev 32:1–8PubMedCrossRefGoogle Scholar
  14. 14.
    Grumann MM, Schlag PM et al. (2001) Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection in colorectal cancer. Ann Surg 233:149–156PubMedCrossRefGoogle Scholar
  15. 15.
    Maslekar S (2006) Transanal endoscopic microsurgery, where are we now? Dig Surg 23:12–22. Epub 2006 Apr 21PubMedCrossRefGoogle Scholar
  16. 16.
    Hestermann U (2005) „Fragile“-Der alte Mensch und die Chirurgie. Chirurg 76:28–34PubMedCrossRefGoogle Scholar
  17. 17.
    Kapiteijn E, Marijnem CAM, Nagtegaal ID et al. (2001) Preoperative radiotherapy comined with total mesorectal exision for respectable rectal cancer. N Engl J Med 345:638–646PubMedCrossRefGoogle Scholar
  18. 18.
    Kathri VP, Petrelli NJ (2005) Extending the frontiers of surgical therapy for hepatic colorectal metastases:is there a limit? J Clin Oncol 23:8490–8499CrossRefGoogle Scholar
  19. 19.
    Krook JE, Moertel CG, Gunderson LL et al. (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715PubMedCrossRefGoogle Scholar
  20. 20.
    Martling A, Holm T, Johannsson H et al. (2001) The Stockhol II trial on preoperative radiotherapy in rectal Carcinoma-Long term follow up of a population- based study. Cancer 92:896–902PubMedCrossRefGoogle Scholar
  21. 21.
    NIH consensus conference (1990) Adjuvant therapy for patients with colon and rectal cancer. Jama 264:1444–1450CrossRefGoogle Scholar
  22. 22.
    Payne JE, Meyer HJ (1997) Independently predictive prognostic variables after resection for colorectal carcinoma. Aust N Z J Surg 67:849–853PubMedGoogle Scholar
  23. 23.
    Pignon T, Horiot JC, Bolla M et al. (1997) Age is not a limitimg factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 42:107–120PubMedCrossRefGoogle Scholar
  24. 24.
    Rödel C, Fietkau R, Keilholz L et al. (1997) Akuttoxizität der simultanen Radiochemotherapie des Rektumkarzinoms. Strahlenther Onkol 173:415–421PubMedGoogle Scholar
  25. 25.
    Sargent DJ et al. (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091–1097PubMedCrossRefGoogle Scholar
  26. 26.
    Sauer R, Becker H, Hohenberger W et al. (2004) Preoperative versus postoperative Chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRefGoogle Scholar
  27. 27.
    S3-Leitlinie der Deutschen Krebsgesellschaft, Leitlinienkonferenz 2004Google Scholar
  28. 28.
    Statistisches Bundesamt in Wiesbaden, 2004Google Scholar
  29. 29.
    Swedish rectal cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987CrossRefGoogle Scholar
  30. 30.
    Tveit KM, Guldvog I, Hagen S et al. (1997) Randomized controlled trial of postoperative radiotherapy and short-term-time-schedule 5-FU against surgery alone in the treatment of Dukes B and C rectal caner. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84:1130–1135PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  1. 1.Klinik für Chirurgie und Chirurgische OnkologieCharité – Universitätsmedizin Berlin, Campus Buch, Robert Rössle Klinik im Helios Klinikum BerlinBerlinDeutschland
  2. 2.Klinik für Radioonkologie und StrahlenheilkundeHelios Klinikum Bad SaarowBad SaarowDeutschland

Personalised recommendations